Pennsylvania Capital Management Inc Pfizer Inc Transaction History

Pennsylvania Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$41.75 - $54.5 $49,223 - $64,255	1,179 Added 23.84%	6,124 $0
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $13,959 - $16,551	300 Added 6.46%	4,945 $259,000
Q1 2022 Apr 15, 2022	SELL	$45.75 - $56.69 $448,350 - $555,562	-9,800 Reduced 67.84%	4,645 $240,000
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $596,867 - $884,756	14,445 New	14,445 $853,000
Q3 2020 Oct 07, 2020	SELL	$31.75 - $37.25 $224,091 - $262,910	-7,058 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $212,586 - $257,899	7,058 New	7,058 $218,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Pennsylvania Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Pennsylvania Capital Management Inc with notifications on news.